Drug Royalty III (Feeder EU), L.P. — Form D/A
Drug Royalty III (Feeder EU), L.P. of WILMINGTON, DE, a pooled investment fund, filed a Form D amendment with the SEC on 2013-08-02. $249.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2013-08-02
- Form: D/A
- Accession: 0001453011-13-000023
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.7
- Amount sold: $249.5M
- Minimum investment: $100K
- Investors: 14
- Date of first sale: 2012-12-21
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-189664
Issuer
- Name: Drug Royalty III (Feeder EU), L.P.
- CIK: 0001566197
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: C/O CORPORATION SERVICE COMPANY, WILMINGTON, DE, 19808
- Phone: 416-863-1865
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Abali J Hoilett | Director | Grand Cayman, E9 |
| William Shaw | Director | Grand Cayman, E9 |
| Ali Hedayat | Director | Toronto, Z4 |
| Behzad Khosrowshahi | Director | Toronto, A6 |
| M. Craig Shepherd | Director | Toronto, A6 |
| Ali Seirafi | Director | Geneva, V8 |
Other filings by this issuer (3)
More